TALA SHIDAIFAT

Tala earned her Doctor of Medicine degree from Jordan University of Science and Technology and is currently pursuing a PhD in Molecular Pharmacology and Drug Discovery.

 

Her research focuses on the role of autoantibodies against GPCRs in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and their potential pharmacological implications in disease treatment. Using advanced laboratory techniques, such as cell signaling assays, she aims to identify drug targets within the GPCR family. Through her work, she strives to contribute to the development of more effective, targeted treatments that can improve patient outcomes.